January 22, 2018 — Baxter International Inc. announced the U.S. Food and Drug Administration (FDA) approval of ...
September 12, 2017 — Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with ...
May 16, 2016 — A study using a stem cell therapy to treat challenging refractory angina (RA) patients demonstrated ...
March 5, 2012 — Baxter International Inc. announced that it initiated a phase III pivotal clinical trial to evaluate the ...
June 17, 2011 — KLAS today announced the release of their highly anticipated "2011 Top 20 Best in KLAS Awards: Medical ...
April 21, 2011 – Baxter International has entered into a definitive agreement to acquire privately-held Prism ...
Baxter Healthcare Corp. received FDA approval in December for the GELFOAM Plus Hemostasis Kit (absorbable gelatin sponge ...
Baxter Healthcare Corp. received FDA 510(k) clearance for its needleless V-Link Luer-activated device (LAD), an IV ...